Back to Search Start Over

Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation

Authors :
Mansi Narula
Uma Lakshmanan
Simon Borna
Janika J. Schulze
Tyson H. Holmes
Nicholas Harre
Matthew Kirkey
Akshaya Ramachandran
Veronica Maria Tagi
Federica Barzaghi
Eyal Grunebaum
Julia E.M. Upton
Vy Hong-Diep Kim
Christian Wysocki
Victoria R. Dimitriades
Kenneth Weinberg
Katja G. Weinacht
Yael Gernez
Bindu K. Sathi
Magdalena Schelotto
Matthew Johnson
Sven Olek
Christoph Sachsenmaier
Maria-Grazia Roncarolo
Rosa Bacchetta
Source :
The Journal of allergy and clinical immunology. 151(1)
Publication Year :
2022

Abstract

Forkhead box protein 3 (FOXP3) is the master transcription factor in CD4We sought to study the type and extent of immunologic abnormalities that remain ill-defined in IPEX, across genetic and clinical heterogeneity.We performed Treg-cell-specific epigenetic quantification and immunologic characterization of severe "typical" (n = 6) and "atypical" or asymptomatic (n = 9) patients with IPEX.Increased number of cells with Treg-cell-Specific Demethylated Region demethylation in FOXP3 is a consistent feature in patients with IPEX, with (1) highest values in those with typical IPEX, (2) increased values in subjects with pathogenic FOXP3 but still no symptoms, and (3) gradual increase over the course of disease progression. Large-scale profiling using Luminex identified plasma inflammatory signature of macrophage activation and TElevated TSDR-demethylated cells, combined with elevation of plasmatic and cellular markers of a polarized type 2 inflammatory immune response, extends our understanding of IPEX diagnosis and heterogeneity.

Subjects

Subjects :
Immunology
Immunology and Allergy

Details

ISSN :
10976825
Volume :
151
Issue :
1
Database :
OpenAIRE
Journal :
The Journal of allergy and clinical immunology
Accession number :
edsair.doi.dedup.....b89fbdb16a8dec9dc59ba6458a6fdaa6